Crank said there are concerns a sale of Walgreens to private equity firm Sycamore Partners—as reported by the Wall Street Journal—could shift focus of the pharmacy giant. The result, he said, could be resulting in fewer stores, shorter hours, and fewer options for customers. In a statement...
Shields is not a traditional specialty pharmacy, but instead represents an evolution to the model. Shields participates in the specialty pharmacy space by building and accelerating hospital-owned specialty pharmacy programs that are integrated with care providers at the point of care. The idea is simp...